What Are the Best Clinical Trial Patient Recruitment Services?

Ask ten sponsors what makes a recruitment service "the best" and you will get ten answers. Some care most about cost per randomized patient. Others have one site bleeding screen failures and just want the bleeding to stop. The honest answer is that the best service is the one whose work actually reaches the coordinator's desk in a usable form.

That sounds obvious. It is not how most of the market works.

Almost everything sold as "patient recruitment" falls into one of three buckets, and they are not interchangeable.

1. Media buyers They run ads. They report impressions, clicks, and raw form fills. What happens after the form fill is somebody else's problem, usually the site's. If your sites already have staff sitting idle waiting to make calls, this can work. Most sites do not.

2. Technology platforms They sell software: a portal, a dashboard, a matching algorithm. The tool may be good. But a tool assumes someone on your side has the hours to operate it. Buying a platform when the real shortage is people tends to add a login, not a patient.

3. Done-for-you enrollment operations Campaign, pre-screening, follow-up, appointment setting, and handoff to the site all handled by one team. The site receives a qualified person with a scheduled visit rather than a spreadsheet of names. This is the model we built TheraNovex around, because the gap in almost every stalled study we reviewed sat between the lead and the visit, not before it.

What separates strong services from weak ones

Five things show up again and again in the programs that hit enrollment:

Protocol-specific screening. Generic "are you interested in a study?" questions produce volume and nothing else. Screening built from the actual inclusion and exclusion criteria produces referrals a coordinator can trust. Persistent follow-up. The average interested patient is not reached on the first call. Programs that stop after one attempt lose most of what they paid for. Scheduling, not handoff. A referral with a confirmed appointment converts at a completely different rate than a name in an inbox. Site-level reporting. If the vendor cannot tell you which site is converting referrals and which one is sitting on them, nobody can fix the underperforming site. Reachable humans. When a site has a question at 4 p.m. on a Friday, somebody answers.

Skip the case studies for a moment and ask these instead:

Who makes the follow-up calls, and how many attempts per patient? Do you pre-screen against my protocol, or against a general condition profile? What does the site actually receive, and in what system? How do you handle a site that stops responding to referrals? What happens in week three if the numbers are below plan?

Vendors who work the full funnel answer these quickly and specifically. Vendors who sell traffic get vague around question three.

Cost per lead is the easiest number to shop and the least useful. A cheaper lead that never converts is more expensive than a costlier referral that shows up. Compare cost per randomized participant, and if a vendor cannot model that with you, treat the omission as information.

If you want a straight assessment of where your study is losing people, request a proposal and we will map your funnel before quoting anything. You can also see how coverage works across sites on our TrialMatch network or talk to our team directly.